NCT02039752Recruiting
Asan Multivessel Registry
Asan Medical Center Registry for Multivessel
Source: ClinicalTrials.gov · Last updated 2 Jan 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 25000 (estimated)
- First submitted
- 14 Jan 2014
- Start date
- 1 Mar 2014
- Primary completion date
- 30 Jun 2030
- Lead sponsor
- Seung-Jung Park
- Diseases
- Coronary artery disease
- NCT number
- NCT02039752
What you commit to
- Study type: Observational
- Planned participants: 25000
- From 1 Mar 2014 to the primary completion date, 30 Jun 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- For prospective cohort, not agreeing to participate with written informed consent form
Who the study is looking for
- Patients with multivessel disease from 1995 in Asan Medical Center
- Age 19 and more
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Asan Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.